9,300 Shares in Adient PLC (NYSE:ADNT) Acquired by Dupont Capital Management Corp

Share on StockTwits

Dupont Capital Management Corp purchased a new position in Adient PLC (NYSE:ADNT) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 9,300 shares of the company’s stock, valued at approximately $214,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ADNT. CWM LLC grew its holdings in shares of Adient by 231.2% in the 2nd quarter. CWM LLC now owns 1,020 shares of the company’s stock worth $25,000 after acquiring an additional 712 shares during the period. Strs Ohio acquired a new stake in Adient during the 2nd quarter valued at $106,000. KCS Wealth Advisory acquired a new stake in Adient during the 2nd quarter valued at $205,000. Point View Wealth Management Inc. acquired a new stake in Adient during the 2nd quarter valued at $210,000. Finally, Fox Run Management L.L.C. acquired a new stake in Adient during the 2nd quarter valued at $216,000. Institutional investors and hedge funds own 97.90% of the company’s stock.

ADNT stock opened at $24.46 on Friday. Adient PLC has a 52-week low of $12.15 and a 52-week high of $26.40. The stock’s fifty day simple moving average is $22.47 and its 200-day simple moving average is $22.02. The company has a quick ratio of 0.88, a current ratio of 1.07 and a debt-to-equity ratio of 1.65. The stock has a market capitalization of $2.33 billion, a price-to-earnings ratio of 4.35 and a beta of 3.22.

Adient (NYSE:ADNT) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.38. Adient had a positive return on equity of 8.35% and a negative net margin of 11.00%. The business had revenue of $3.92 billion for the quarter, compared to analysts’ expectations of $4.02 billion. During the same quarter last year, the firm earned $1.30 earnings per share. The business’s revenue was down 5.4% on a year-over-year basis. As a group, analysts anticipate that Adient PLC will post 1.25 earnings per share for the current fiscal year.

A number of equities research analysts have commented on ADNT shares. Wolfe Research started coverage on Adient in a report on Tuesday, October 8th. They set a “market perform” rating and a $21.00 target price on the stock. Bank of America cut Adient from a “buy” rating to a “neutral” rating and set a $28.00 target price on the stock. in a report on Friday, September 13th. UBS Group cut Adient from a “buy” rating to a “neutral” rating and lowered their target price for the company from $30.00 to $27.00 in a report on Thursday, September 12th. Barclays lowered their target price on Adient from $29.00 to $28.00 and set an “overweight” rating on the stock in a report on Wednesday, October 2nd. Finally, ValuEngine cut Adient from a “strong-buy” rating to a “buy” rating in a report on Friday, November 1st. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $21.57.

About Adient

Adient plc designs, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. It operates through three segments: Seating, Seat Structures and Mechanisms (SS&M), and Interiors. The Seating segment produces seat systems for automotive and other mobility applications, as well as various components of seat systems, including foams, trims, and fabrics.

Further Reading: Treasury Bonds

Institutional Ownership by Quarter for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.